Steve Ryan Wood
Burglar Alarm in Payson, UT
License number
Utah 8693717-6502
Issued Date
Aug 7, 2013
Expiration Date
Mar 31, 2015
Category
Burglar Alarm
Type
Burglar Alarm Company Agent
Address
Address
Payson, UT
Personal information
See more information about Steve Ryan Wood at radaris.comName
Address
Phone
5862 Exeter Dr, Morgan, UT 84050
3189 W Gemstone Dr, West Jordan, UT 84084
3189 Gemstone Dr, West Jordan, UT 84084
4324 W 3780 S, Salt Lake City, UT 84120
Professional information
See more information about Steve Ryan Wood at trustoria.com
Oral Formulations For Promoting Cellular Purification
Oral Formulations For Promoting Cellular Purification
US Patent:
2013007, Mar 21, 2013
Filed:
Mar 14, 2012
Appl. No.:
13/420547
Inventors:
Angela Mastaloudis - Holladay UT, US
Steve Wood - Santaquin UT, US
Jamie Louis Barger - Verona WI, US
Richard Weindruch - Madison WI, US
Tomas Alberto Prolla - Madison WI, US
Mark Bartlett - Orem UT, US
Scott B. Ferguson - Highland UT, US
Steve Wood - Santaquin UT, US
Jamie Louis Barger - Verona WI, US
Richard Weindruch - Madison WI, US
Tomas Alberto Prolla - Madison WI, US
Mark Bartlett - Orem UT, US
Scott B. Ferguson - Highland UT, US
Assignee:
NSE Products, Inc. - Provo UT
International Classification:
A61K 36/87, A61K 36/752, A61K 36/63, A61K 31/192, A61K 36/185, A61K 31/12, A61K 36/736, A61K 36/258, A61K 36/31, A61K 31/122
US Classification:
424 941, 424755, 424736, 424766, 424769, 514678, 514679, 424735, 424728, 514569
Abstract:
An oral formulation includes a plurality of agents that promote cellular detoxification. Agents can be included that modulate expression of Nrf2-associated genes upon ingestion of the oral formulation by a subject, wherein the Nrf2-associated genes include at least one gene encoding intrinsic antioxidants, and at least one gene encoding cellular detoxifiers. In addition, at least one of the plurality of agents attenuates inflammation.
Oral Formulations For Counteracting Effects Of Aging
Oral Formulations For Counteracting Effects Of Aging
US Patent:
2012013, May 31, 2012
Filed:
May 24, 2011
Appl. No.:
13/115027
Inventors:
Angela Mastaloudis - Holladay UT, US
Steve Wood - Santaquin UT, US
Richard Weindruch - Madison WI, US
Tomas Alberto Prolla - Madison WI, US
Jamie Louis Barger - Verona WI, US
Mark Bartlett - Orem UT, US
Scott B. Ferguson - Highland UT, US
Joseph Chang - Sandy UT, US
Steve Wood - Santaquin UT, US
Richard Weindruch - Madison WI, US
Tomas Alberto Prolla - Madison WI, US
Jamie Louis Barger - Verona WI, US
Mark Bartlett - Orem UT, US
Scott B. Ferguson - Highland UT, US
Joseph Chang - Sandy UT, US
International Classification:
A61K 36/062, A61K 31/122, A61K 36/79, A61K 36/87, A61P 25/00, A61K 36/736, A61K 36/185, A61P 3/00, A61P 15/00, A61P 21/00, A61K 36/258, A61K 36/41
US Classification:
424 941, 42419515, 514690
Abstract:
An oral formulation as described herein can comprise pomegranate extract, panax ginseng extract, and , where each is present in an amount effective to counteract and/or prevent effects of aging in a subject when administered to the subject. The effects of aging can include age-related changes in gene expression.
Identifying Markers Of Caloric Restriction And Caloric Restriction Mimetics
Identifying Markers Of Caloric Restriction And Caloric Restriction Mimetics
US Patent:
2013017, Jul 11, 2013
Filed:
Jun 15, 2012
Appl. No.:
13/525230
Inventors:
Angela Mastaloudis - Holladay UT, US
Steve Wood - Santaquin UT, US
Tomas Alberto Prolla - Madison WI, US
Jamie Louis Barger - Verona WI, US
Richard Weindruch - Madison WI, US
Joseph Chang - Sandy UT, US
Steve Wood - Santaquin UT, US
Tomas Alberto Prolla - Madison WI, US
Jamie Louis Barger - Verona WI, US
Richard Weindruch - Madison WI, US
Joseph Chang - Sandy UT, US
Assignee:
NSE Products, Inc. - Provo UT
International Classification:
C12Q 1/68
US Classification:
506 9, 506 17, 536 2431, 506 16, 506 18, 435 611
Abstract:
Markers of caloric restriction (CR) can be identified in a selected tissue by exposing an animal to CR conditions and selecting one or more genes differentially expressed in response to CR conditions in multiple subject groups. A candidate compound can be screened for likely ability to mimic the effects of CR when administered to an animal by comparing the tissue levels of expression products of the genes in animals treated with the candidate compound to those of animals subjected to CR.